• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Japan Closed System Drug Transfer Device Market

    ID: MRFR/Pharma/47915-HCR
    200 Pages
    Garvit Vyas
    September 2025

    Japan Closed System Drug Transfer Device Market Research Report By Type (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Japan Closed System Drug Transfer Device Market -Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Japan Closed System Drug Transfer Device Market Summary

    The Japan Closed System Drug Transfer Device market is projected to grow significantly from 36 USD Million in 2024 to 120 USD Million by 2035.

    Key Market Trends & Highlights

    Japan Closed System Drug Transfer Device Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 11.57 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 120 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 36 USD Million, reflecting the current demand for drug transfer solutions.
    • Growing adoption of closed system drug transfer devices due to increasing safety regulations is a major market driver.

    Market Size & Forecast

    2024 Market Size 36 (USD Million)
    2035 Market Size 120 (USD Million)
    CAGR (2025-2035) 11.57%

    Major Players

    C.R. Bard, Smiths Medical, Vygon, Baxter International, West Pharmaceutical Services, Thermo Fisher Scientific, InnoMedicus, Medinstill Development, Fresenius Kabi, Cardinal Health, Murphy Healthcare, B. Braun Melsungen, Cisco, Halyard Health

    Japan Closed System Drug Transfer Device Market Trends

    A greater emphasis on safety and regulatory compliance in healthcare settings is driving notable changes in the Japan closed system drug transfer device market. Healthcare professionals' growing awareness of the need to prevent medication exposure and contamination is a major factor driving the market.

    In Japan, healthcare facilities are forced to implement safer medication handling procedures due to strict laws set by the Ministry of Health, Labour, and Welfare. The market is being greatly shaped by this government effort, which is encouraging more healthcare professionals to invest in closed system medication transfer systems.

    Additionally, as Japanese hospitals and clinics seek to modernize their current systems and integrate new technologies that improve efficiency and safety, market prospects are growing. Manufacturers have a great chance to innovate and set their goods apart from the competition thanks to the increasing use of cutting-edge technology in medical devices, such as integration with digital monitoring systems.

    As healthcare professionals choose gadgets that are easier to use while meeting safety standards, recent developments show a shift towards more ergonomic and user-friendly designs. The need for safe drug transfer techniques is also being impacted by Japan's aging population, as older populations typically need medical attention more frequently.

    The market for closed-system drug transfer devices is anticipated to change in response to new healthcare demands and technological breakthroughs, while patient safety remains a top priority.

    All things considered, the market for closed-system drug transfer devices in Japan is expanding rapidly due to changes in the population, technical developments, and regulatory requirements, paving the way for improved healthcare safety in the future.

    Japan Closed System Drug Transfer Device Market Drivers

    Market Segment Insights

    Closed System Drug Transfer Device Market Type Insights

    The Japan Closed System Drug Transfer Device Market, focusing on the Type segment, encompasses innovative technologies that ensure the safe handling of hazardous drugs. Two prominent types within this market are the Membrane-to-membrane systems and Needleless Systems, each contributing to the growth and efficiency of drug transfer processes.

    Membrane-to-membrane systems are designed to create a secure barrier that minimizes the risk of contamination and leakage, making them crucial for the safe administration of chemotherapy agents and other high-risk medications.

    This type is gaining traction owing to enhanced safety features and the ability to streamline workflows in high-pressure healthcare settings. On the other hand, Needleless Systems have revolutionized medication administration by removing the need for traditional needles, significantly reducing needle-stick injuries, and improving overall safety for healthcare professionals and patients alike.

    The move towards needle-free technology aligns with broader trends in healthcare focusing on minimizing risks associated with drug handling, thereby improving operational efficiency and patient outcomes.

    These systems play a pivotal role, particularly in Japan, as the country emphasizes high-quality healthcare standards and the protection of medical staff from occupational hazards.

    Closed System Drug Transfer Device Market Component Insights

    The Japan Closed System Drug Transfer Device Market is significantly shaped by its Component segment, which encompasses various critical elements essential for safe drug handling.

    Vial Access Devices are crucial as they ensure secure and sterile access to vials, reducing the risk of contamination, while Syringe Safety Devices play a pivotal role in minimizing needlestick injuries, a major concern in healthcare facilities. Accessories, although sometimes overlooked, provide necessary auxiliary functions that enhance device efficiency and usability in clinical settings.

    Bag/Line Access Devices hold importance for drug delivery in intravenous therapies, ensuring that drugs are transferred without exposure to harmful agents. This Component segment collectively fosters a safer environment for both healthcare professionals and patients, driven by ongoing advancements in technology and a rising demand for effective drug transfer solutions.

    The growth of this sector is further stimulated by the increasing focus on patient safety and the stringent regulations surrounding drug administration techniques in Japan's healthcare industry. As these components continue to evolve, they will play an integral part in shaping the future of the Japan Closed System Drug Transfer Device Market.

    Closed System Drug Transfer Device Market Closing Mechanism Insights

    The Closing Mechanism segment of the Japan Closed System Drug Transfer Device Market plays a vital role in ensuring the safe transfer and handling of hazardous drugs. Various mechanisms, including Push to Turn Systems and Color-to-color Alignment Systems, are designed to prevent leaks and contamination, addressing stringent safety regulations in Japan's healthcare settings.

    The Leur Lock Systems are recognized for their robust connection methods, promoting universal compatibility and reliable performance across different equipment. Click to Lock Systems provide an intuitive locking mechanism, enhancing user convenience and reducing the chances of accidental disengagement during drug transfer.

    The significance of these mechanisms not only lies in their functionality but also in their ability to comply with Japan's rigorous standards for healthcare products. Emerging trends indicate a growing demand for innovative and efficient closing mechanisms as Japan continues to emphasize patient safety and medication efficacy.

    This trend is supported by increased awareness of the risks associated with hazardous drug handling, thus promoting the development and adoption of advanced technological solutions in the market.

    Closed System Drug Transfer Device Market Technology Insights

    The Technology segment of the Japan Closed System Drug Transfer Device Market showcases a diversified array of innovations tailored to enhance safety and efficiency in healthcare settings. Compartmentalized Devices are gaining traction due to their capacity to minimize exposure risk during drug handling, providing an essential layer of safety for healthcare professionals.

    Meanwhile, Diaphragm-Based Devices play a critical role by ensuring the integrity of drug transfers, efficiently preventing contamination while maintaining ease of use. Air Filtration Devices are significant in the segment as they effectively mitigate airborne risks, an increasingly important factor in hospital environments focusing on infection control.

    Each of these technologies contributes to a safer drug handling process, addressing the urgent need for effective solutions to reduce hazardous exposure in clinical settings. As the Japan Closed System Drug Transfer Device Market evolves, these technologies will continue to be pivotal, driving demand for higher standards of safety in pharmaceutical practices and responsiveness to regulatory requirements.

    Closed System Drug Transfer Device Market End-user Insights

    The End-users segment of the Japan Closed System Drug Transfer Device Market plays a crucial role in ensuring safe and effective medication administration in various healthcare settings. Hospitals and clinics are primary users of these devices, as they are essential for minimizing the risk of hazardous drug exposure and maintaining sterile environments.

    With a growing patient population and increasing instances of chronic diseases, the demand for specialized services in hospitals and clinics is expected to rise, contributing significantly to the market.

    Specialty centers, which focus on specific treatment areas such as oncology and compounding, are also critical End-users, as they require advanced drug transfer technologies to handle high-risk medications safely.

    The importance of these centers lies in their ability to cater to unique patient needs and enhance treatment outcomes while ensuring safety standards. Other healthcare facilities, such as home healthcare services and outpatient clinics, increasingly recognize the importance of closed system drug transfer devices to protect healthcare workers and patients alike.

    As the healthcare landscape in Japan evolves, the increased focus on patient safety and regulatory compliance will drive the growth of the Japan Closed System Drug Transfer Device Market, with End-users adapting to the latest technological advancements to enhance their service delivery.

    Get more detailed insights about Japan Closed System Drug Transfer Device Market -Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The Japan Closed System Drug Transfer Device Market is characterized by an increasingly competitive landscape driven by a heightened focus on safety and efficacy in drug delivery systems. As healthcare providers strive to minimize the risks associated with hazardous drug exposure, the demand for closed system drug transfer devices (CSTD) is on the rise.

    This sector showcases a variety of players offering innovative solutions designed to meet regulatory standards and safeguard healthcare professionals and patients from potential contamination.

    With a landscape in flux due to technological advancements and regulatory developments, market participants are establishing their presence through strategic partnerships, product innovations, and targeted marketing initiatives. As a result, companies must actively monitor competitors' operations and adapt their strategies to remain relevant and gain market share in this evolving market.

    C.R. Bard

    C.R. Bard has established a significant footprint in the Japan Closed System Drug Transfer Device Market, showcasing its strengths in design and manufacturing. The company is renowned for its commitment to producing high-quality, reliable CSTDs that address the unique needs of the Japanese healthcare system.

    C.R. Bard's robust R&D capabilities allow it to innovate continuously, ensuring that its products meet the high standards expected in Japan, where regulatory compliance and safety are paramount considerations.

    The company also benefits from a well-structured distribution network, allowing for effective penetration into hospitals and healthcare facilities. Its established reputation for excellence has positioned C.R. Bard as a trusted provider of closed systems, enabling it to maintain a competitive edge as the market grows.

    Smiths Medical

    Smiths Medical has also secured a reputable position within the Japan Closed System Drug Transfer Device Market, distinguished by its advanced technology and comprehensive product offerings designed for medication administration and patient safety.

    The company provides a range of key products, including various CSTD options that prioritize user safety and handling efficiency. Smiths Medical's continuous focus on product development aligns with Japan's evolving regulatory landscape, showcasing its strengths in innovation and responsiveness to market needs.

    Moreover, Smiths Medical has entered into strategic partnerships and potential mergers and acquisitions to enhance its market presence, allowing it to expand its influence across the region.

    With a dedicated team focused on the unique requirements of the Japanese market, Smiths Medical continues to solidify its commitment to improving outcomes in healthcare, thus positioning itself effectively against competitors in this key segment.

    Key Companies in the Japan Closed System Drug Transfer Device Market market include

    Industry Developments

    Recent developments in the Japan Closed System Drug Transfer Device Market indicate significant advancements and focus on safety and efficiency in medical facilities. Companies like C.R. Bard, Baxter International, and West Pharmaceutical Services have been enhancing their product offerings to meet the growing demand for safety-engineered devices.

    Notably, in June 2023, Vygon announced a strategic collaboration with a leading Japanese pharmaceutical company to drive innovation in drug transfer safety, showcasing the increasing importance of local partnerships.

    Moreover, in July 2022, Thermo Fisher Scientific expanded its presence in Japan by opening a new facility focused on production innovations in drug delivery systems, reflecting the market's growth potential. In terms of mergers and acquisitions, there are reports of C.R. Bard considering strategic acquisitions to bolster its market share in Japan, although no specific transactions have been finalized as of October 2023.

    The increasing focus on patient safety regulations and the rising incidence of oncology treatments are contributing to the overall market valuation growth, positioning Japan as a pivotal region for investments in closed-system drug transfer technologies. The market is expected to continue evolving with the need for improved healthcare solutions.

    Market Segmentation

    Closed System Drug Transfer Device Market Type Outlook

    • Membrane-to-membrane
    • Needleless System

    Closed System Drug Transfer Device Market End-usersOutlook

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Closed System Drug Transfer Device Market Component Outlook

    • Vial Access Devices
    • Syringe Safety Devices
    • Accessories
    • Bag/Line Access Devices

    Closed System Drug Transfer Device Market Technology Outlook

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Closed System Drug Transfer Device Market Closing Mechanism Outlook

    • Push to Turn System
    • Color-to-color Alignment System
    • Leur Lock Systems
    • Click to Lock Systems

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 32.1(USD Million)
    MARKET SIZE 2024 36.0(USD Million)
    MARKET SIZE 2035 120.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 11.567% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED C.R. Bard, Smiths Medical, Vygon, Baxter International, West Pharmaceutical Services, Thermo Fisher Scientific, InnoMedicus, Medinstill Development, Fresenius Kabi, Cardinal Health, Murphy Healthcare, B. Braun Melsungen, Cisci, Halyard Health
    SEGMENTS COVERED Type, Component, Closing Mechanism, Technology, End-Users
    KEY MARKET OPPORTUNITIES Increasing cancer treatment demand, Regulatory support for safety standards, Rising focus on healthcare worker protection, Expansion of home healthcare services, Technological advancements in device design
    KEY MARKET DYNAMICS increasing cancer prevalence, stringent safety regulations, technological advancements, rising healthcare expenditure, growing awareness of hazardous drugs
    COUNTRIES COVERED Japan

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market size of the Japan Closed System Drug Transfer Device Market in 2024?

    The Japan Closed System Drug Transfer Device Market is expected to be valued at 36.0 million USD in 2024.

    What is the expected market size for the Japan Closed System Drug Transfer Device Market by 2035?

    By 2035, the Japan Closed System Drug Transfer Device Market is anticipated to reach a value of 120.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the market between 2025 and 2035?

    The market is expected to exhibit a CAGR of 11.567 percent from 2025 to 2035.

    Which segment of the Japan Closed System Drug Transfer Device Market is expected to grow the fastest?

    The Needleless System segment is projected to see significant growth, reaching 70.0 million USD by 2035.

    How much is the Membrane to Membrane segment valued at in 2024?

    The Membrane to Membrane segment is valued at 15.0 million USD in 2024.

    Who are the key players in the Japan Closed System Drug Transfer Device Market?

    Major players include C.R. Bard, Smiths Medical, Baxter International, and West Pharmaceutical Services, among others.

    What are the main applications driving the market growth?

    The primary applications driving growth include safe handling of hazardous drugs in medical facilities.

    What challenges is the Japan Closed System Drug Transfer Device Market currently facing?

    Challenges include regulatory compliance and the need for education on the safe use of these devices.

    How has the competitive landscape of the market changed?

    The competitive landscape has seen increased innovation and product development among key players.

    What opportunities exist for investors in the Japan Closed System Drug Transfer Device Market?

    Opportunities for investors include advancements in technology and rising demand for safety in drug administration.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. Japan Closed System Drug Transfer Device Market, BY Type (USD Million)
    45. Membrane to Membrane
    46. Needleless System
    47. Japan Closed System Drug Transfer Device Market, BY Component (USD Million)
    48. Vial Access Devices
    49. Syringe Safety Devices
    50. Accessories
    51. Bag/Line Access Devices
    52. Japan Closed System Drug Transfer Device Market, BY Closing Mechanism (USD Million)
    53. Push to Turn System
    54. Color-to-color Alignment System
    55. Leur Lock Systems
    56. Click to Lock Systems
    57. Japan Closed System Drug Transfer Device Market, BY Technology (USD Million)
    58. Compartmentalize Devices
    59. Diaphragm-Based Devices
    60. Air Filtration Devices
    61. Japan Closed System Drug Transfer Device Market, BY End-Users (USD Million)
    62. Hospitals & Clinics
    63. Specialty Centers
    64. Others
    65. Competitive Landscape
    66. Overview
    67. Competitive Analysis
    68. Market share Analysis
    69. Major Growth Strategy in the Closed System Drug Transfer Device Market
    70. Competitive Benchmarking
    71. Leading Players in Terms of Number of Developments in the Closed System Drug Transfer Device Market
    72. Key developments and growth strategies
    73. New Product Launch/Service Deployment
    74. Merger & Acquisitions
    75. Joint Ventures
    76. Major Players Financial Matrix
    77. Sales and Operating Income
    78. Major Players R&D Expenditure. 2023
    79. Company Profiles
    80. C.R. Bard
    81. Financial Overview
    82. Products Offered
    83. Key Developments
    84. SWOT Analysis
    85. Key Strategies
    86. Smiths Medical
    87. Financial Overview
    88. Products Offered
    89. Key Developments
    90. SWOT Analysis
    91. Key Strategies
    92. Vygon
    93. Financial Overview
    94. Products Offered
    95. Key Developments
    96. SWOT Analysis
    97. Key Strategies
    98. Baxter International
    99. Financial Overview
    100. Products Offered
    101. Key Developments
    102. SWOT Analysis
    103. Key Strategies
    104. West Pharmaceutical Services
    105. Financial Overview
    106. Products Offered
    107. Key Developments
    108. SWOT Analysis
    109. Key Strategies
    110. Thermo Fisher Scientific
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. InnoMedicus
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. Medinstill Development
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. Fresenius Kabi
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. Cardinal Health
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. Murphy Healthcare
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. B. Braun Melsungen
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. Cisci
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. Halyard Health
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. References
    165. Related Reports
    166. Japan Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    167. Japan Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY COMPONENT, 2019-2035 (USD Billions)
    168. Japan Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY CLOSING MECHANISM, 2019-2035 (USD Billions)
    169. Japan Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    170. Japan Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY END-USERS, 2019-2035 (USD Billions)
    171. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    172. ACQUISITION/PARTNERSHIP
    173. MARKET SYNOPSIS
    174. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY TYPE
    175. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY COMPONENT
    176. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY CLOSING MECHANISM
    177. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY TECHNOLOGY
    178. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY END-USERS
    179. KEY BUYING CRITERIA OF CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    180. RESEARCH PROCESS OF MRFR
    181. DRO ANALYSIS OF CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    182. DRIVERS IMPACT ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    183. RESTRAINTS IMPACT ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    184. SUPPLY / VALUE CHAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    185. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2025 (% SHARE)
    186. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    187. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2025 (% SHARE)
    188. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019 TO 2035 (USD Billions)
    189. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2025 (% SHARE)
    190. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019 TO 2035 (USD Billions)
    191. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    192. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    193. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END-USERS, 2025 (% SHARE)
    194. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END-USERS, 2019 TO 2035 (USD Billions)
    195. BENCHMARKING OF MAJOR COMPETITORS

    Japan Closed System Drug Transfer Device Market Segmentation

    • Closed System Drug Transfer Device Market By Type (USD Million, 2019-2035)

      • Membrane to Membrane
      • Needleless System

    • Closed System Drug Transfer Device Market By Component (USD Million, 2019-2035)

      • Vial Access Devices
      • Syringe Safety Devices
      • Accessories
      • Bag/Line Access Devices

    • Closed System Drug Transfer Device Market By Closing Mechanism (USD Million, 2019-2035)

      • Push to Turn System
      • Color-to-color Alignment System
      • Leur Lock Systems
      • Click to Lock Systems

    • Closed System Drug Transfer Device Market By Technology (USD Million, 2019-2035)

      • Compartmentalize Devices
      • Diaphragm-Based Devices
      • Air Filtration Devices

    • Closed System Drug Transfer Device Market By End-Users (USD Million, 2019-2035)

      • Hospitals & Clinics
      • Specialty Centers
      • Others
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027